ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1720

Cardiovascular Risk Management in Rheumatoid Arthritis Is Nurse Led Intervention Effective?

Fiona Niddrie1 and Gabor AC Major2, 1Rheumatology, Bone and Joint Institute; Royal Newcastle Centre, Newcastle, Australia, 2Rheumatology, Bone&Joint Institute; Royal Newcastle Centre, Newcastle, Australia

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, rheumatoid arthritis (RA) and risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Care of Patients With Rheumatoid Arthritis

Session Type: Abstract Submissions (ARHP)

Background/Purpose:

There is a recognised increase in the incidence of heart disease in patients with rheumatoid arthritis (RA)

Surveys of usual practice however frequently show a significant gap in the management of cardiovascular (CV) risk factors1.

This study was undertaken with the aim of reviewing our experience and if a management gap was found, to see if this could be effectively and efficiently addressed by a nurse led initiative

AIM

To identify the extent of awareness and management of CV risk factors in patients with RA attending a general rheumatology clinic

To explore the feasibility of a nurse led assessment programme and evaluate its effectiveness in managing CV risk

Methods:

The medical records of all patients with RA were audited at the time of their scheduled review visit for the extent of CV risk assessment that had been completed and recorded by the treating rheumatologist in the previous 12 months.

Patients were then asked about their knowledge of CV risk and about assessments that had been undertaken through their family physician

A standard letter highlighting the increase in CV risk in RA together with the patient’s CV risk factor assessment was then sent to the family physician, with recommendation to address any apparent  deficiencies

Patients were seen again 6 months later and the completeness and effectiveness of CV risk management reviewed

Results:

Patient awareness of the increased CV risk in RA was only 19%

Initial review showed that in the prior 12 months 86% of patients had had a blood pressure (BP) check;  31% had adequate serum lipid and 39% had glucose/HbA1c measurement;  42% had their weight and height recorded and 75% of smokers had received counselling

At the 6 month review of the first 150 patients all patients had had their BP checked.  79 (53%)were on active treatment.  17 had their treatment changed and 1 was newly started

Comprehensive assessment of lipids rose from 31% of patients to 60%; and for glucose/Hba1c  from 39% to 62% . Two patients had treatment changes and one was newly started

Counselling of the 30 patients who smoked and the 103 with abnormal body mass index (BMI) resulted in 2 patients quitting smoking.  59 (39%) showed an improved BMI with 2 returning to ideal body weight

Average time per patient encounter was 26 mins at an estimated cost, excluding laboratory costs, of $21.03 AUS per patient encounter

Conclusion:

1 A significant gap in the routine management of CV risk factors was identified

2 Patient awareness of the increased risk of CV disease in RA is low

3 A nurse led intervention programme is feasible and effective in addressing the problems of CV risk factor management in patients with RA, but needs to be adequately resourced

Reference   1  Webster R J et al.  MJA 2009; 191: 324-329


Disclosure:

F. Niddrie,
None;

G. A. Major,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-risk-management-in-rheumatoid-arthritis-is-nurse-led-intervention-effective/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology